Skip to main content

Clinical trials

Schedule appointment (352) 294-5400
Doctor talking to patient
  • NEULARK

    The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2"…

    Investigators
    Adolfo Ramirez-Zamora, Irene A Malaty
    Ages
    40 Years - 80 Years
    Sexes
    All
  • Study in Parkinson Disease of Exercise (SPARX3)

    This study is a Phase 3 multi-site, randomized, evaluator-masked, study of endurance treadmill exercise on changes in the Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part III score at 12 months among persons with…

    Ages
    40 Years - 80 Years
    Sexes
    All